Prevalence and predictors of analgesic use during early pregnancy in a Brazilian population
Frontiers in Pharmacology · 05.03.2026 · 17
DOI: 10.3389/fphar.2026.1730483 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 05.03.2026. Verfasst von Marcella Tapias Passoni und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Reproductive Toxicology, Department of Pharmacology, Federal University of Paraná, Curitiba, Brazil. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Although the use of analgesics is generally not recommended during pregnancy, several studies have reported a high prevalence of use among pregnant women. In this study, we assessed the prevalence of early pregnancy use of analgesics in a Brazilian population, as well as potential sociodemographic and lifestyle predictors.
Methods
Pregnant women up to 16 weeks of gestation (N = 275) were recruited in Curitiba, Brazil, and specifically asked about the use of paracetamol, dipyrone, ibuprofen, acetylsalicylic acid, and diclofenac, including common brand names and indications.
Results
The consumption of any analgesic up to the point of recruitment was reported by 61.5% of women, most commonly for the treatment of headaches. Paracetamol was the most used analgesic (55.3%), followed by dipyrone (13.5%) and ibuprofen (12%), and the use of more than one analgesic was reported by 18.5% of participants. The self-reported health status was a significant predictor. Women reporting fair/poor health were more likely to use any analgesic and paracetamol than those who reported good/excellent health status (OR = 3.05; 95% CI = 1.44–6.50). Among paracetamol users, women reporting the consumption of paracetamol and other analgesics ingested more paracetamol pills than those participants who reported the use of paracetamol-only. Similarly, the use of pharmaceuticals other than analgesics was also positively associated with the heavy use of paracetamol (OR = 3.70; 95% CI = 1.08–12.74).
Discussion
Overall, the high prevalence of analgesic use during early pregnancy, particularly paracetamol and the combination of different analgesics, highlights the need for further research across different global regions and their potential implications for maternal and fetal health.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Reproductive Toxicology, Department of Pharmacology, Federal University of Paraná, Curitiba, Brazil.
- Laboratory of Animal Reproductive and Endocrine Physiology, Department of Physiology, Federal University of Paraná, Curitiba, Brazil.
Zitieren
APA
Passoni, M. T., Rompkovski, M. R., Santana Rios, V. A., Krebs Ribeiro, D. C., Maltoni, A. A., Basso, C. G., Tolouei, S. E. L., Franco, J. M., Manfroi da Silva, B., Martino-Andrade, A. J., & CARES Study Group (2026). Prevalence and predictors of analgesic use during early pregnancy in a Brazilian population. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1730483
Vancouver
Passoni MT, Rompkovski MR, Santana Rios VA, Krebs Ribeiro DC, Maltoni AA, Basso CG, et al. Prevalence and predictors of analgesic use during early pregnancy in a Brazilian population. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1730483
BibTeX
@article{Passoni2026,
author = {Passoni, Marcella Tapias and Rompkovski, Mariana Regina and Santana Rios, Vitória Aline and Krebs Ribeiro, Daniele Cristine and Maltoni, Amanda Atuati and Basso, Carla Giovana and Tolouei, Sara Emilia Lima and Franco, Juliana Machado and Manfroi da Silva, Bianca and Martino-Andrade, Anderson Joel and CARES Study Group, CARES Study Group},
title = {Prevalence and predictors of analgesic use during early pregnancy in a Brazilian population},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1730483}
}
EUVIMED